Discover PwC’s four cutting edge digital tax & regulatory solutions and how they can add value to your business, help you complying with new laws, stay up to date with upcoming changes in legislation and regulatory.Continue reading Pharma & Life Sciences: 4 cutting edge digital tax & regulatory solutions
Dear pharma & life sciences colleagues,
It was a pleasure to welcome you to our webinar: PwC Pharma & Life Sciences Webinar: COVID-19 impact on the ITX and regulatory DNA.
Attached below you can download the presentation.Continue reading PwC Pharma & Life Sciences Webinar: COVID-19 impact on the ITX and regulatory DNA
As the COVID-19 situation develops, tax and regulatory specialists within the pharmaceutical & life sciences industry are increasingly facing complex challenges. Efficient and pragmatic solutions have to be realised, with fewer resources, in line with the changing local legislation.
The exchange of information is the best practice in this industry to support and inspire you in your daily business.Continue reading PwC Pharma & Life Sciences Webinar: COVID-19 impact on the ITX and regulatory DNA – Thursday 28. May 2020, 10:30 CEST
I hope you had a relaxing summer time.
Do you face troubles in order to be up to date with all the required legislation changes in various countries in the Regulatory Pharma & Life Sciences field AND combine it with your supply chain and tax strategy?
I am happy to inform you that we have recently launched our Pharma & Life Sciences Regulatory Radar, to strive to assist you in that regard.Continue reading Cutting Edge Digital Solution – Pharma & Life Sciences Regulatory Radar
Happy to invite you to have a look to our latest PwC Webinar on precision medicines and the respective hot topics in the VAT field for the US, Europe, Switzerland and Asia. Continue reading Webinar on indirect tax issues in Precision Medicine
I am pleased to invite you to our Webinar on Precision Medicine
and Accurate Indirect Tax
During this digital presentation our panel of experts will give you an overview of possible indirect tax implications within the pharma sector. This panel consists of many tax specialists of the pharmaceutical sector and PwC’s international indirect tax experts. Experts, who are dedicated to the pharmaceutical industry.
I will use my time slot to discuss the implications for Switzerland including which countries will be covered.
You will have the opportunity to exchange your experiences and views on the issue with other international leaders.
- Date: November 6th 2018 November 8th 2018
- Time: 10am – 11 am CET 12am – 1pm CET
Are you a pharmaceutical company selling drugs outlined in the list of special drugs and therapies (“Spezialitätenliste”) in Switzerland?
If yes, you could benefit from the following information in connection with Swiss VAT.
I am pleased to invite you to our Pharma & Life sciences
During our Get together, we will talk about VAT, customs, direct tax and data privacy issues in the pharmaceutical and life science sector.
- Date: Thursday, 26 April 2018
- Time: 8:30 – 10:30 am
- Place: PwC, St. Jakobs-Strasse 25, 4002 Basel
Take a look at our complete handout here.